Your browser doesn't support javascript.
loading
Bamlanivimab and Etesevimab Improve Symptoms and Associated Outcomes in Ambulatory Patients at Increased Risk for Severe Coronavirus Disease 2019: Results From the Placebo-Controlled Double-Blind Phase 3 BLAZE-1 Trial.
Chen, Peter; Behre, Gerhard; Hebert, Corey; Kumar, Princy; Farmer Macpherson, Lisa; Graham-Clarke, Peita Louise; De La Torre, Inmaculada; Nichols, Russell M; Hufford, Matthew M; Patel, Dipak R; Naegeli, April N.
Afiliación
  • Chen P; Department of Medicine, Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.
  • Behre G; Clinic for Internal Medicine I, Dessau Medical Centre, Dessau-Rosslau, Germany.
  • Hebert C; NOLA Research Works, New Orleans, Louisiana, USA.
  • Kumar P; Georgetown University, Washington, District of Columbia, USA.
  • Farmer Macpherson L; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Graham-Clarke PL; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • De La Torre I; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Nichols RM; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Hufford MM; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Patel DR; Eli Lilly and Company, Indianapolis, Indiana, USA.
  • Naegeli AN; Eli Lilly and Company, Indianapolis, Indiana, USA.
Open Forum Infect Dis ; 9(5): ofac172, 2022 May.
Article en En | MEDLINE | ID: mdl-35493124
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos